Document ID: chunk:federal_register_of_legislation:F2022C00276:clause:1_7
Version: federal_register_of_legislation:F2022C00276
Segment Type: clause
Provision Reference: sch 1 cl 7
Character Range: 8486–9454

7  Transitional arrangements
 (1) In this section:
  former instrument means the Therapeutic Goods Order No. 88 Standards for donor selection, testing, and minimising infectious disease transmission via therapeutic goods that are human blood and blood components, human tissues and human cellular therapy products, as in force immediately before the commencement of the repeal instrument.
  repeal instrument means the Therapeutic Goods (Standards for Biologicals) Repeal Instrument 2021.
  transition period means the period beginning on 30 September 2021 and ending on 30 September 2022.
 (2) Despite the repeal of the former instrument by the repeal instrument, the former instrument continues to apply for the duration of the transition period, such that the standard for human cell and tissue products constituted by the former instrument may be conformed with as an alternative to the standard for human cell and tissue products constituted by this instrument.